The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 745K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

19 articles for PM Woster


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Discovery of a new class of histone deacetylase inhibitors with a novel zinc binding group.EBI
Medical University of South Carolina
Structure-activity study for (bis)ureidopropyl- and (bis)thioureidopropyldiamine LSD1 inhibitors with 3-5-3 and 3-6-3 carbon backbone architectures.EBI
John Hopkins University
Synthesis and evaluation of novel cyclic Peptide inhibitors of lysine-specific demethylase 1.EBI
Medical University of South Carolina
Low molecular weight amidoximes that act as potent inhibitors of lysine-specific demethylase 1.EBI
Wayne State University
(Bis)urea and (bis)thiourea inhibitors of lysine-specific demethylase 1 as epigenetic modulators.EBI
Wayne State University
Terminally alkylated polyamine analogues as chemotherapeutic agents.EBI
Wayne State University
S-(5'-deoxy-5'-adenosyl)-1-aminoxy-4-(methylsulfonio)-2-cyclopentene (AdoMao): an irreversible inhibitor of S-adenosylmethionine decarboxylase with potent in vitro antitrypanosomal activity.EBI
Wayne State University
 
Restricted rotation analogs of S-adenosylmethionine: synthesis, evaluation as inhibitors of S-adenosylmethionine decarboxylase, and potential use as selective antitrypanosomal agentsEBI
TBA
 
-cyano-substituted analogoues of decarboxylated S-adenosylmethionine as enzyme activated, irreversible inhibitors of S-adenosylmethionine decarboxylaseEBI
TBA
Mechanism-based inhibitors of the aspartyl protease plasmepsin II as potential antimalarial agents.EBI
Wayne State University
Synthesis and evaluation of small molecule inhibitors of LSD1 for use against MYCN-expressing neuroblastoma.EBI
Medical University of South Carolina
Novel alkylpolyaminoguanidines and alkylpolyaminobiguanides with potent antitrypanosomal activity.EBI
Wayne State University
3,5-Diamino-1,2,4-triazoles as a novel scaffold for potent, reversible LSD1 (KDM1A) inhibitors.EBI
Medical University of South Carolina
Polyamine-based small molecule epigenetic modulators.EBI
Wayne State University
Ligand modifications to reduce the relative resistance of multi-drug resistant HIV-1 protease.EBI
Wayne State University
Recent advances in the development of polyamine analogues as antitumor agents.EBI
Johns Hopkins University
Polyaminohydroxamic acids and polyaminobenzamides as isoform selective histone deacetylase inhibitors.EBI
Wayne State University
Alkyl-substituted polyaminohydroxamic acids: a novel class of targeted histone deacetylase inhibitors.EBI
Wayne State University
Cyclic peptide inhibitors of lysine-specific demethylase 1 with improved potency identified by alanine scanning mutagenesis.EBI
Medical University of South Carolina